These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1718918)

  • 21. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
    Habib FK; Ross M; Tate R; Chisholm GD
    Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Zinc levels in prostatic fluid of patients with prostate pathologies].
    Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
    Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical and histological studies on prostates in castrated dogs after treatment with androstanediol, oestradiol and cyproterone acetate.
    Tunn U; Senge T; Schenck B; Neumann F
    Acta Endocrinol (Copenh); 1979 Jun; 91(2):373-84. PubMed ID: 88858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Histochemical study of human prostate. I. Zinc localization (author's transl)].
    Arai R
    Nihon Hinyokika Gakkai Zasshi; 1979 Feb; 70(2):159-68. PubMed ID: 86631
    [No Abstract]   [Full Text] [Related]  

  • 25. [Investigation of trace elements in hair of patients with prostate carcinoma, benign prostatic hypertrophy, and normal controls].
    Ouyang SY; Li SL
    Hunan Yi Ke Da Xue Xue Bao; 2000 Jun; 25(3):279-80. PubMed ID: 12212167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cefminox sodium penetration into prostatic tissue with and without inflammation.
    Sasagawa I; Yamaguchi O; Shiraiwa Y
    Int Urol Nephrol; 1991; 23(6):569-72. PubMed ID: 1722784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone metabolism by homogenates of human prostates with benign hyperplasia: effect of tissular concentrations of zinc, magnesium and copper.
    Sinquin G; Morfin R; Charles JF; Floch HH
    J Steroid Biochem; 1982 Oct; 17(4):395-400. PubMed ID: 6182394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penetration of fleroxacin into prostatic secretion and prostatic adenoma tissue.
    Kees F; Naber KG; Schumacher H; Grobecker H
    Chemotherapy; 1988; 34(6):437-43. PubMed ID: 2468456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings: Testosterone, dihydrotestosterone, zinc and cadmium in prostatic tissue.
    Habib FK; Hammond GL; Stitch SR; Dawson JB
    J Endocrinol; 1975 Jun; 65(3):34P. PubMed ID: 50395
    [No Abstract]   [Full Text] [Related]  

  • 30. [Zinc in the human prostate].
    Larue JP; Morfin RF; Charles JF
    J Urol (Paris); 1985; 91(7):463-8. PubMed ID: 2418124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of radix urticae extract and its several secondary extracts on blood SHBG in benign prostate hyperplasia].
    Schmidt K
    Fortschr Med; 1983 Apr; 101(15):713-6. PubMed ID: 6189775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observations with Bazoton in the management of prostatic hyperplasia.
    Romics I
    Int Urol Nephrol; 1987; 19(3):293-7. PubMed ID: 2444548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-peptide, testosterone, estrogen, cortisol and zinc in patients with benign hyperplasia of the prostate.
    Dunzendorfer U; Drahovsky D
    Urol Int; 1980; 35(5):369-74. PubMed ID: 6158779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma.
    Anderson RU; Fair WR
    Invest Urol; 1976 Sep; 14(2):137-40. PubMed ID: 61187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.
    Carilla E; Briley M; Fauran F; Sultan C; Duvilliers C
    J Steroid Biochem; 1984 Jan; 20(1):521-3. PubMed ID: 6200701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulmus macrocarpa Hance improves benign prostatic hyperplasia by regulating prostatic cell apoptosis.
    Rho J; Seo CS; Park HS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
    J Ethnopharmacol; 2019 Apr; 233():115-122. PubMed ID: 30508623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is the prostatic adenoma of hormonal origin].
    Bercovici JP; Morfin R; Charles JF
    Nouv Presse Med; 1975 Feb; 4(7):475-8. PubMed ID: 48234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic antibacterial factor. Identity and significance.
    Fair WR; Couch J; Wehner N
    Urology; 1976 Feb; 7(2):169-77. PubMed ID: 54972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zinc and magnesium serum levels in patients with benign prostatic hyperplasia (BPH) before and after prazosin therapy.
    Dutkiewicz S
    Mater Med Pol; 1995; 27(1):15-7. PubMed ID: 8569270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metallothionein expression in human prostate gland.
    Bataineh ZM; Nusier MK
    Saudi Med J; 2003 Nov; 24(11):1246-9. PubMed ID: 14647563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.